Nicole Baumgarth

Nicole Baumgarth

Auto-generated profile, based on publicly available information

Nicole Baumgarth

Lyme and Tickborne Diseases Research and Education Institute, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University 1 W. Harry Feinstone Department of Molecular Microbiology and Immunology Baltimore, MD

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2010 in Nature Reviews Immunology
Verified
Journal Article
Closed access
NBNicole Baumgarth
Nicole Baumgarth

17 July 2000 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NBNicole Baumgarth
Nicole Baumgarth
OHOmeta C. Herman
Ometa C. Herman
GJGina C. Jager
Gina C. Jager
LBLorena Brown
Lorena Brown
LHLeonore A. Herzenberg
Leonore A. Herzenberg
JCJianzhu Chen
Jianzhu Chen
We have studied the role of secreted immunoglobulin (Ig)M in protection from infection with influenza virus and delineated the relative contributions of B-1 versus B-2 cell–derived IgM in this process. Mice deficient in secreted IgM but capable of expressing surface IgM and secreting other Ig classes show significantly reduced virus clearance and survival rates compared with wild-type controls. Irradiation chimeras in which only either B-1 or B-2 cells lack the ability to secrete IgM show mortality rates similar to those of mice in which neither B-1 nor B-2 cells secrete IgM. Dependence on both sources of IgM for survival is partially explained by findings in allotype chimeras that broadly cross-reactive B-1 cell–derived natural IgM is present before infection, whereas virus strain–specific, B-2 cell–derived IgM appears only after infection. Furthermore, lack of IgM secreted from one or both sources significantly impairs the antiviral IgG response. Reconstitution of chimeras lacking B-1 cell–derived IgM only with IgM-containing serum from noninfected mice improved both survival rates and serum levels of virus-specific IgG. Thus, virus-induced IgM must be secreted in the presence of natural IgM for efficient induction of specific IgG and for immune protection, identifying B-1 and B-2 cell–derived IgM antibodies as nonredundant components of the antiviral response.

5 January 2005 in Springer Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
NBNicole Baumgarth
Nicole Baumgarth
JTJames W. Tung
James W. Tung
LHLeonore A. Herzenberg
Leonore A. Herzenberg

15 December 2008 in Journal of Experimental Medicine
Verified
Journal Article
Open access
YCYoun Soo Choi
Youn Soo Choi
NBNicole Baumgarth
Nicole Baumgarth
B-1 cells are known to contribute most of the “natural antibodies” that are secreted in the steady state, antibodies which are crucial for protection against many pathogens including influenza virus. Whether the CD5+ B-1a subset plays a role during an active immune response is incompletely understood. In contrast to recent data suggesting a passive role for B-1a cells, data provided here show strong highly localized activation of B-1 cells in the draining lymph nodes of the respiratory tract after influenza infection. B-1 cells are identified as a major source for both steady state and infection-induced local virus-neutralizing IgM. The CD5+ B-1a subset is the main B-1 cell subset generating this response. B-1a cell responses are generated by their increased local accumulation rather than by antigen-specific expansion. Our study reveals that during infection with influenza, CD5-expressing B-1a cells respond to and contribute to protection, presumably without the need for B cell receptor–mediated antigen-specific signals, which are known to induce the death of B-1a cells rather than activation. With that, our data reveal fundamental differences in the response regulation of B-1 and B-2 cells during an infection.

9 September 2016 in Frontiers in Immunology
Verified
Journal Article
Open access
NBNicole Baumgarth
Nicole Baumgarth
A small subset of B cells, termed B-1 cells, with developmental origins, phenotype and functions that are distinct from those of conventional B cells exist in mice, which contributes the vast majority of spontaneously produced “natural” IgM. Natural IgM is constitutively produced, even in the absence of microbiota, and fulfills many distinct functions in tissue-homeostasis and host-defense. B-1 cells also respond with IgM production to innate signals and pathogen exposure, while maintaining steady state levels natural IgM. Thus, within the B-1 cell pool, cells of distinct and heterogeneous functionality must exist to facilitate these different functions. This review considers three factors that may contribute to this heterogeneity: First, developmental differences regarding the origins of the precursors, second, tissue-specific signals that may differentially affect B-1 cells in the tissue compartments, and last responsiveness to self antigens as well as innate and antigen-specific signals. All three are likely to shape the repertoire and responsiveness of B-1 cells to homeostatic and antigen-induced signals and thus to contribute to the functional heterogeneity among these innate-like B cells.

18 October 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
YCYoun Soo Choi
Youn Soo Choi
JDJacquelyn A. Dieter
Jacquelyn A. Dieter
KRKristina Rothaeusler
Kristina Rothaeusler
ZLZheng Luo
Zheng Luo
NBNicole Baumgarth
Nicole Baumgarth
Natural IgM antibodies secreted in the absence of antigenic challenge are important contributors to antimicrobial immunity and tissue homeostasis. Early studies identified BM and, to a lesser extent the spleen, as main tissue sources of this spontaneously secreted IgM. However, the responsible B‐cell subset has never been identified. Using multicolor flow cytometry, cell sorting and chimeric mice in which B‐1 and B‐2 cells and their secreted antibodies are distinguished by their Ig‐allotype, we unequivocally identify the natural IgM‐secreting cells in spleen and, for the first time, in the BM as IgM+ IgDlo/‐CD19hi CD43+ CD5+/− B‐1 cells. The newly identified population of BM B‐1 cells shows many of the phenotypic characteristics of splenic B‐1 cells but is distinct from B‐1 cells in the peritoneal cavity, which generate at best very small amounts of IgM. Antibody‐secreting spleen and BM B‐1 cells are distinct also from terminally differentiated plasma cells generated from antigen‐induced conventional B cells, as they express high levels of surface IgM and CD19 and lack expression of CD138. Overall, these data identify populations of non‐terminally differentiated B‐1 cells in spleen and BM as the most significant producers of natural IgM.